bibliographic entry 5530265 [be/5530265]
https://w3id.org/oc/corpus/be/5530265

is a
content
  • Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010; 11: 1029–1035. PMID: 20965785
references